|
|
市场分析报告
|
Global Female Sexual Dysfunction Treatment Drug Market Growth 2024-2030
... countries. Segmentation by Type: Estrogen Therapy Ospemifene Flibanserin Bremelanotide Others Segmentation by Application ...
Global Women Sexual Disorder Drugs Treating Market Growth 2024-2030
... countries. Segmentation by Type: Estrogen Therapy Ospemifene Flibanserin Bremelanotide Others Segmentation by Application ...
2025-2030 Global Female Sexual Dysfunction Treatment Drug Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region
... Pharmaceuticals Lupin By Type Estrogen Therapy Ospemifene Flibanserin Bremelanotide Others By Application Hospital ...
2025-2030 Global Women Sexual Disorder Drugs Treating Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region
... Pharmaceuticals Lupin By Type Estrogen Therapy Ospemifene Flibanserin Bremelanotide Others By Application Hospital ...
Non Hormonal Contraceptives Market for Women’s Health by Target Indication (Bacterial Vaginosis, Contraception, Endometriosis, Postmenopausal Osteoporosis, Uterine Fibroids, Vaginitis and Others), Type of Molecule (Biologic and Small Molecule), Purpose of Therapy (Treatment of Disease and Management of Symptoms), Mechanism of Action (Antagonist, Agonist, Inhibitor and Modulator), Route of Administration (intramuscular, intravaginal, intravenous, oral, subcutaneous, topical, transdermal and others), and Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2021-2030
The non hormonal contraceptives market is expected to reach USD 1.8 billion in 2021 and anticipated to grow at a CAGR of 22% during the forecast period 2021-2030. According to the World Health Organization (WHO), around one-third of clinical conditions ...
Postmenopausal Vaginal Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
The 7 major postmenopausal vaginal atrophy markets reached a value of US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 5.04% during 2024-2034. The postmenopausal ...
Global Female Sexual Dysfunction Treatment Drug Market Research Report 2025(Status and Outlook)
... Market Segmentation (by Type) Estrogen Therapy Ospemifene Flibanserin Bremelanotide Others Market Segmentation ...
Global Women Sexual Disorder Drugs Treating Market Research Report 2025(Status and Outlook)
... Market Segmentation (by Type) Estrogen Therapy Ospemifene Flibanserin Bremelanotide Others Market Segmentation ...
|
|
|
|
